Table 2. Demographics of the 7 patients with positive BRAFV600E mutation on follow-up analysis.
| No. | Age | Gender | Size (mm) | Inital US-FNA | Follow-up US-FNA | Final diagnosis |
| 1 | 46 | F | 8 | non-diagnostic | suspicious for malignancy | cPTC based on surgery |
| 2 | 57 | F | 10 | non-diagnostic | malignancy | Follow-up evaluation based on cytology |
| 3 | 44 | F | 4 | benign | indeterminate | cPTC based on surgery |
| 4 | 45 | F | 7 | benign | suspicious for malignancy | cPTC based on surgery |
| 5 | 38 | M | 8 | atypia | benign | cPTC based on surgery |
| 6 | 54 | F | 5 | atypia | suspicious for malignancy | cPTC based on surgery |
| 7 | 58 | F | 6 | atypia | suspicious for malignancy | FVPTC based on surgery |
F: women, M: men
cPTC: conventional papillary thyroid carcinoma, FVPTC: follicular variant papillary thyroid carcinoma